© 1994 Oxford University Press
OTHER |
Localization of the gene encoding the
2/
-subunits of the L-type voltage-dependent calcium channel to chromosome 7q and analysis of the segregation of flanking markers in malignant hyperthermia susceptible families
Department of Cell Biology and Histology and Faculty of Medical Sciences, Catholic University of Nijmegen PO Box 9101, 6500 HB Nijmegen, The Netherlands
1Department of Applied Physiology, University of Ulm D-89069 Ulm, Germany
2Department of Genetics, The Hospital for Sick Children Toronto, Ontario M5G 1X8, Canada
3Department of Molecular and Medical Genetics, University of Toronto Ontario M5S 1A8, Canada
4Department of Human Genetics, Faculty of Medical Sciences, Catholic University of Nijmegen PO Box 9101, 6500 HB Nijmegen, The Netherlands
5Department of Intensive Care, University Hospital of Antwerp B2650 Edegem, Belgium
6Department of Pharmacology and Cell Biophysics, University of Cincinnati College of Medicine Cincinnati, OH 45267-0575, USA
7Academic Unit of Anaesthesia, St James's University Hospital Leeds LS9 7TF, UK
8Department of Genetics, University of Leeds Leeds LS2 9JT, UK
9Klinik und Poliklinik f
r Kinderheilkunde D-48129 Münster, Germany
*To whom correspondence should be addressed
Received March 3, 1994; Revised April 15, 1994; Accepted April 15, 1994
Malignant hyperthermia susceptibility (MHS) is an autosomal dominant disorder of skeletal muscle which manifests as a potentially fatal hypermetabolic crisis triggered by commonly used anaesthetic agents. This demonstration of genetic heterogeneity in MHS prompted the investigation of the roles played by calcium regulatory proteins other than the ryanodine receptor (RYR1), which is known to be linked to MHS in fewer than half of the European MHS families studies to date. Previously, we have excluded the genes encoding the skeletal muscle L-type voltage-dependent calcium channel
1-, ß1-and
-subunits as candidates for MHS. In this report, we describe the cloning and partial DNA sequence analysis of the gene encoding the
2/
-subunits, CACNL2A, and its localization onthe proximal long arm of chromosome 7q. A new dinucleotide repeat marker close to CACNL2A was identified at the D7S849 locus and tested for linkage in six MHS families. D7S849 and flanking genetic markers were found to co-segregate with the MHS locus through 11 meioses in one, three-generation family. These results suggest that mutations in or near CACNL2A may be involved in some forms of this heterogeneous disorder.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
R. S. Litman and H. Rosenberg Malignant Hyperthermia: Update on Susceptibility Testing JAMA, June 15, 2005; 293(23): 2918 - 2924. [Abstract] [Full Text] [PDF] |
||||
![]() |
T D Graves and M G Hanna Neurological channelopathies Postgrad. Med. J., January 1, 2005; 81(951): 20 - 32. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Iohom, D. Fitzgerald, and A. J. Cunningham Principles of pharmacogenetics--implications for the anaesthetist Br. J. Anaesth., September 1, 2004; 93(3): 440 - 450. [Full Text] [PDF] |
||||
![]() |
A. Tammaro, A. Bracco, S. Cozzolino, M. Esposito, A. Di Martino, G. Savoia, L. Zeuli, G. Piluso, S. Aurino, and V. Nigro Scanning for Mutations of the Ryanodine Receptor (RYR1) Gene by Denaturing HPLC: Detection of Three Novel Malignant Hyperthermia Alleles Clin. Chem., May 1, 2003; 49(5): 761 - 768. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Yamakage and A. Namiki Calcium channels - basic aspects of their structure, function and gene encoding; anesthetic action on the channels - a review: [Revue : notions de base sur la structure, la fonction et l'encodage genetique des canaux calciques et action des anesthesiques sur ces canaux] Can J Anesth, February 1, 2002; 49(2): 151 - 164. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Tilgen, F. Zorzato, B. Halliger-Keller, F. Muntoni, C. Sewry, L. M. Palmucci, C. Schneider, E. Hauser, F. Lehmann-Horn, C. R. Muller, et al. Identification of four novel mutations in the C-terminal membrane spanning domain of the ryanodine receptor 1: association with central core disease and alteration of calcium homeostasis Hum. Mol. Genet., December 1, 2001; 10(25): 2879 - 2887. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Rueffert, D. Olthoff, C. Deutrich, B. Thamm, and U. G. Froster Homozygous and heterozygous Arg614Cys mutations (1840C{->}T) in the ryanodine receptor gene co-segregate with malignant hyperthermia susceptibility in a German family Br. J. Anaesth., August 1, 2001; 87(2): 240 - 245. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. L. Robinson and P. M. Hopkins Editorial III: A breakthrough in the genetic diagnosis of malignant hyperthermia Br. J. Anaesth., February 1, 2001; 86(2): 166 - 168. [Full Text] [PDF] |
||||
![]() |
R. Felix Channelopathies: ion channel defects linked to heritable clinical disorders J. Med. Genet., October 1, 2000; 37(10): 729 - 740. [Abstract] [Full Text] |
||||
![]() |
P. M. Hopkins Malignant hyperthermia: advances in clinical management and diagnosis Br. J. Anaesth., July 1, 2000; 85(1): 118 - 128. [Full Text] [PDF] |
||||
![]() |
M. W. Berchtold, H. Brinkmeier, and M. Muntener Calcium Ion in Skeletal Muscle: Its Crucial Role for Muscle Function, Plasticity, and Disease Physiol Rev, July 1, 2000; 80(3): 1215 - 1265. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. L. Brown, A. N. Pollock, K. G. Couchman, M. Hodges, D. O. Hutchinson, R. Waaka, P. Lynch, T. V. McCarthy, and K. M. Stowell A novel ryanodine receptor mutation and genotype-phenotype correlation in a large malignant hyperthermia New Zealand Maori pedigree Hum. Mol. Genet., June 12, 2000; 9(10): 1515 - 1524. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Dumas, Z. Pausova, V. Kren, D. Krenova, M. Pravenec, M. Dumont, D. Ely, M. Turner, Y. Sun, J. Tremblay, et al. Contribution of Autosomal Loci and the Y Chromosome to the Stress Response in Rats Hypertension, February 1, 2000; 35(2): 568 - 573. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-Q. WU, E. NICKERSON, L. G SHAFFER, K. KEPPLER-NOREUIL, and A. MUILENBURG A case of Williams syndrome with a large, visible cytogenetic deletion J. Med. Genet., December 1, 1999; 36(12): 931 - 932. [Full Text] |
||||
![]() |
F. Lehmann-Horn and K. Jurkat-Rott Voltage-Gated Ion Channels and Hereditary Disease Physiol Rev, October 1, 1999; 79(4): 1317 - 1372. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.G. Benatar Calcium channelopathies QJM, March 1, 1999; 92(3): 133 - 141. [Full Text] [PDF] |
||||
![]() |
V. Barone, O. Massa, E. Intravaia, A. Bracco, A. Di Martino, V. Tegazzin, S. Cozzolino, and V. Sorrentino Mutation screening of the RYR1 gene and identification of two novel mutations in Italian malignant hyperthermia families J. Med. Genet., February 1, 1999; 36(2): 115 - 118. [Abstract] [Full Text] |
||||
![]() |
M. Richter, L. Schleithoff, T. Deufel, F. Lehmann-Horn, and A. Herrmann-Frank Functional Characterization of a Distinct Ryanodine Receptor Mutation in Human Malignant Hyperthermia-susceptible Muscle J. Biol. Chem., February 21, 1997; 272(8): 5256 - 5260. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. E. Koch, I. Bodi, A. Schwartz, and G. Varadi Architecture of Ca2+ Channel Pore-lining Segments Revealed by Covalent Modification of Substituted Cysteines J. Biol. Chem., October 27, 2000; 275(44): 34493 - 34500. [Abstract] [Full Text] [PDF] |
||||










